| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0008-6363(97)00137-5 |
| P698 | PubMed publication ID | 9463632 |
| P50 | author | Zsuzsanna K Zsengeller | Q59157435 |
| P2093 | author name string | A L Salzman | |
| C Szabó | |||
| S Cuzzocrea | |||
| B Zingarelli | |||
| P433 | issue | 2 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| myocardial ischemia | Q6947906 | ||
| P304 | page(s) | 205-215 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase | |
| P478 | volume | 36 |
| Q44760164 | 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice |
| Q43791925 | 5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5'-diphosphate ribose) polymerase, reduces myocardial infarct size |
| Q34520738 | Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injury |
| Q35586887 | Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes |
| Q35566493 | An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart |
| Q28582227 | BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity |
| Q73487675 | BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase |
| Q73336283 | Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion |
| Q24674975 | Beneficial effects of n-acetylcysteine on ischaemic brain injury |
| Q43188677 | Beneficial effects of raxofelast (IRFI 016), a new hydrophilic vitamin E-like antioxidant, in carrageenan-induced pleurisy |
| Q77917908 | Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis |
| Q28360091 | Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat |
| Q41393165 | Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide |
| Q44520629 | Critical role of reactive nitrogen species in lung ischemia-reperfusion injury |
| Q42289851 | DNA single-strand break-induced DNA damage response causes heart failure |
| Q43264688 | Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock |
| Q35027754 | Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the liver injury caused by ischaemia-reperfusion: a comparison with radical scavengers |
| Q43261298 | Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock |
| Q34344802 | Effects of inosine on reperfusion injury after cardiopulmonary bypass |
| Q62268607 | Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury |
| Q35044253 | Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation |
| Q34521289 | Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats |
| Q24301686 | GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat |
| Q43540661 | GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation. |
| Q59550503 | H2O2 and PARS mediate lung P-selectin upregulation in acute pancreatitis |
| Q44518204 | Hsp70 attenuates hypoxia/reoxygenation-induced activation of poly(ADP-ribose) synthetase in the nucleus of adult rat cardiomyocytes |
| Q35008854 | Hydroxyl radical in living systems and its separation methods |
| Q35028471 | Inhibition of poly(ADP-ribose) synthetase (PARS) and protection against peroxynitrite-induced cytotoxicity by zinc chelation |
| Q44462694 | Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis |
| Q43185132 | Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts |
| Q43762486 | Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment |
| Q34129753 | Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes |
| Q92256639 | Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases |
| Q43886869 | Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor |
| Q55069213 | Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. |
| Q37014196 | Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review |
| Q48243280 | Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats. |
| Q38954348 | Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases |
| Q28080057 | Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP) |
| Q33610044 | Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules |
| Q34963325 | Peroxynitrite in myocardial ischemia-reperfusion injury |
| Q44641686 | Peroxynitrite in reperfusion arrhythmias and its whole blood chemiluminescence results |
| Q30443968 | Peroxynitrite inhibits myofibrillar protein function in an in vitro assay of motility |
| Q44133546 | Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure |
| Q46799848 | Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation |
| Q46491668 | Poly (adp-ribose) synthetase inhibition reduces oxidative and nitrosative organ damage after thermal injury |
| Q85945858 | Poly(ADP-ribose) polymerase 1 activation links ischemic acute kidney injury to interstitial fibrosis |
| Q35192798 | Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion |
| Q44381641 | Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia: its role in brain edema and cell death |
| Q44533623 | Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass |
| Q98945207 | Poly(ADP-ribose) polymerase inhibition: past, present and future |
| Q36161842 | Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury. |
| Q74298195 | Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells |
| Q44591581 | Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest |
| Q48197211 | Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia |
| Q74449667 | Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation |
| Q77758126 | Protective effects of melatonin in zymosan-activated plasma-induced paw inflammation |
| Q43930666 | Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor |
| Q77614308 | Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig |
| Q43848053 | Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. |
| Q89921455 | Role of Akt Activation in PARP Inhibitor Resistance in Cancer |
| Q77309271 | Role of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shock |
| Q43177277 | Role of peroxynitrite and activation of poly (ADP-ribose) synthase in the vascular failure induced by zymosan-activated plasma |
| Q36426742 | Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors |
| Q77089411 | Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion |
| Q74819865 | Role of poly(ADP-ribose)synthetase in inflammation |
| Q36211215 | Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes |
| Q28345810 | Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences |
| Q73689474 | The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia |
| Q36853236 | Therapeutic applications of PARP inhibitors: anticancer therapy and beyond |
| Q46950214 | Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat. |
| Q37072777 | miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1. |
Search more.